As the world is getting ready for the revolution of personalized medicine, pharmacogenetics in particular, choosing laboratory partners has been one of the main focus Abomics has set for the year 2018.
Working with the most qualified and leading genetic labs has been a high priority for Abomcis since the beginning.
Dante Labs leverages only the best genetic testing technologies worldwide. They benefit of a full portfolio of sequencing platforms, from benchtop to the factory-scale instruments that deliver the right level of speed, capacity and costs. Currently Dante Labs has doctors in more than 20 countries, offices in Italy, USA and a recently opened office in Finland.
As the partnership with Dante Labs was on the pipeline, Abomics was thrilled when the two top of the range companies agreed to proceed with the negotiations.
As Abomics is the leading company within pharmacogenetics, is was a natural co-operation for the two to join forces. Abomics will provide high quality pharmacogenetical reporting for all Dante Lab customers starting from Oct. 10th 2018.
Both companies believe in long, sustainable and profitable partnership!